Swiss National Bank raised its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 1.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,173,724 shares of the medical equipment provider’s stock after buying an additional 14,300 shares during the quarter. Swiss National Bank owned about 418,484.69% of Hologic worth $43,064,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Stratos Wealth Partners LTD. grew its holdings in shares of Hologic by 0.6% during the second quarter. Stratos Wealth Partners LTD. now owns 4,954 shares of the medical equipment provider’s stock valued at $225,000 after purchasing an additional 30 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Hologic by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 20,803 shares of the medical equipment provider’s stock valued at $944,000 after purchasing an additional 85 shares during the last quarter. Symphony Asset Management LLC grew its holdings in shares of Hologic by 0.4% during the second quarter. Symphony Asset Management LLC now owns 28,005 shares of the medical equipment provider’s stock valued at $1,271,000 after purchasing an additional 108 shares during the last quarter. Cutter & CO Brokerage Inc. grew its holdings in shares of Hologic by 1.7% during the second quarter. Cutter & CO Brokerage Inc. now owns 11,530 shares of the medical equipment provider’s stock valued at $523,000 after purchasing an additional 190 shares during the last quarter. Finally, Louisiana State Employees Retirement System grew its holdings in shares of Hologic by 1.2% during the second quarter. Louisiana State Employees Retirement System now owns 17,400 shares of the medical equipment provider’s stock valued at $790,000 after purchasing an additional 200 shares during the last quarter. 96.41% of the stock is owned by institutional investors.

Several equities analysts have recently commented on the company. Zacks Investment Research raised Hologic from a “sell” rating to a “hold” rating in a report on Tuesday, October 31st. Needham & Company LLC reissued a “buy” rating and issued a $50.00 price objective on shares of Hologic in a report on Friday, November 3rd. BidaskClub lowered Hologic from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Bank of America Corporation reissued a “neutral” rating and issued a $48.00 price objective (up from $44.00) on shares of Hologic in a report on Friday, July 21st. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $45.00 price objective (down from $48.00) on shares of Hologic in a report on Monday, October 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $47.54.

Hologic, Inc. (NASDAQ:HOLX) opened at $39.62 on Wednesday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.79. The stock has a market capitalization of $11,183.05, a price-to-earnings ratio of 20.12, a price-to-earnings-growth ratio of 1.96 and a beta of 0.93. Hologic, Inc. has a one year low of $35.76 and a one year high of $46.80.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.01. The firm had revenue of $802.90 million during the quarter, compared to analyst estimates of $792.54 million. Hologic had a return on equity of 21.69% and a net margin of 24.70%. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period last year, the company posted $0.52 EPS. equities research analysts predict that Hologic, Inc. will post 2.12 earnings per share for the current year.

WARNING: “Swiss National Bank Increases Holdings in Hologic, Inc. (HOLX)” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://theolympiareport.com/2017/11/15/swiss-national-bank-increases-holdings-in-hologic-inc-holx.html.

In other Hologic news, Director Lawrence M. Levy sold 7,139 shares of the stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $39.04, for a total transaction of $278,706.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Karleen Marie Oberton sold 1,256 shares of the stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $39.29, for a total value of $49,348.24. Following the transaction, the vice president now directly owns 9,406 shares of the company’s stock, valued at $369,561.74. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 25,667 shares of company stock valued at $969,299. 0.79% of the stock is currently owned by corporate insiders.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.